CA1238578A - Forme pharmaceutique orale d'etoposide - Google Patents

Forme pharmaceutique orale d'etoposide

Info

Publication number
CA1238578A
CA1238578A CA000476750A CA476750A CA1238578A CA 1238578 A CA1238578 A CA 1238578A CA 000476750 A CA000476750 A CA 000476750A CA 476750 A CA476750 A CA 476750A CA 1238578 A CA1238578 A CA 1238578A
Authority
CA
Canada
Prior art keywords
composition
etoposide
weight
acid
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000476750A
Other languages
English (en)
Inventor
Ismat Ullah
Selima Begum
Bernard C. Nunning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of CA1238578A publication Critical patent/CA1238578A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA000476750A 1984-03-19 1985-03-18 Forme pharmaceutique orale d'etoposide Expired CA1238578A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19
US591,144 1984-03-19

Publications (1)

Publication Number Publication Date
CA1238578A true CA1238578A (fr) 1988-06-28

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000476750A Expired CA1238578A (fr) 1984-03-19 1985-03-18 Forme pharmaceutique orale d'etoposide

Country Status (28)

Country Link
JP (1) JPS60209516A (fr)
KR (1) KR850006136A (fr)
AT (1) AT392904B (fr)
AU (1) AU571308B2 (fr)
BE (1) BE901963A (fr)
CA (1) CA1238578A (fr)
CH (1) CH662731A5 (fr)
DE (1) DE3509741A1 (fr)
DK (1) DK164535C (fr)
EG (1) EG17521A (fr)
ES (1) ES8702140A1 (fr)
FI (1) FI84023C (fr)
FR (1) FR2561104B1 (fr)
GB (1) GB2155789B (fr)
GR (1) GR850688B (fr)
IE (1) IE58340B1 (fr)
IL (1) IL74615A (fr)
IT (1) IT1187640B (fr)
LU (1) LU85812A1 (fr)
MY (1) MY101916A (fr)
NL (1) NL8500739A (fr)
NO (1) NO170569C (fr)
NZ (1) NZ211078A (fr)
OA (1) OA07968A (fr)
PT (1) PT80131B (fr)
SE (1) SE8501312L (fr)
YU (1) YU45243B (fr)
ZA (1) ZA851935B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (fr) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (de) * 1974-11-07 1976-05-13 Universal Oil Prod Co Verfahren zum betrieb einer verbrennungsmaschine
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
FR2410504A1 (fr) * 1977-12-05 1979-06-29 Air Liquide Procede de reglage de securite d'un reacteur chimique et installation de reaction d'oxydation mettant en oeuvre ce procede
DE2809543A1 (de) * 1978-03-06 1979-09-13 Werner Henke Verfahren und vorrichtung zum neutralisieren von gasen bei oel- und gasbohrungen
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤

Also Published As

Publication number Publication date
EG17521A (en) 1990-06-30
FI851040L (fi) 1985-09-20
YU45243B (en) 1992-05-28
OA07968A (fr) 1987-01-31
FR2561104B1 (fr) 1988-04-08
GB8506943D0 (en) 1985-04-24
BE901963A (fr) 1985-09-18
NO170569C (no) 1992-11-04
IL74615A (en) 1988-07-31
FI84023C (fi) 1991-10-10
ATA81985A (de) 1990-12-15
DE3509741A1 (de) 1985-09-26
AT392904B (de) 1991-07-10
AU3897585A (en) 1985-09-26
PT80131A (en) 1985-04-01
ES541370A0 (es) 1986-12-16
JPS60209516A (ja) 1985-10-22
GB2155789A (en) 1985-10-02
ZA851935B (en) 1985-10-30
DK122285D0 (da) 1985-03-18
NZ211078A (en) 1987-08-31
KR850006136A (ko) 1985-10-02
NL8500739A (nl) 1985-10-16
SE8501312L (sv) 1985-09-20
LU85812A1 (fr) 1985-12-12
DK122285A (da) 1985-09-20
ES8702140A1 (es) 1986-12-16
IL74615A0 (en) 1985-06-30
FI851040A0 (fi) 1985-03-15
GB2155789B (en) 1987-10-21
IE850686L (en) 1985-09-19
MY101916A (en) 1992-02-15
IE58340B1 (en) 1993-09-08
NO170569B (no) 1992-07-27
PT80131B (pt) 1987-10-20
YU42085A (en) 1988-02-29
GR850688B (fr) 1985-07-08
DK164535B (da) 1992-07-13
IT1187640B (it) 1987-12-23
DK164535C (da) 1992-11-30
CH662731A5 (de) 1987-10-30
IT8519897A0 (it) 1985-03-14
NO851022L (no) 1985-09-20
FR2561104A1 (fr) 1985-09-20
AU571308B2 (en) 1988-04-14
FI84023B (fi) 1991-06-28
SE8501312D0 (sv) 1985-03-18

Similar Documents

Publication Publication Date Title
US4713246A (en) Etoposide oral dosage form
US4885281A (en) Sucralfate suspension
JP3678745B2 (ja) 高濃度アセトアミノフェン溶液含有ゼラチンカプセル
RU2260429C2 (ru) Составы моксифлоксацина, содержащие поваренную соль
US6656505B2 (en) Method for forming an aqueous flocculated suspension
WO1994025008A1 (fr) Compositions pharmaceutiques contenant de la polyvinylpyrrolidone et un tri-ester, et procede pour leur formation
US3282789A (en) Stable liquid colloidal tannate compositions
WO2008070950A1 (fr) Formulations de solutions pharmaceutiques pour une encapsulation dans des capsules de gélatine ou autres formes posologiques
IE63182B1 (en) Instant oral-release capsule containing nifedipine
WO2000030619A1 (fr) Solution d'ibuprofene auto-emulsifiante et sa capsule de gelatine souple
US4927638A (en) Etoposide solutions
CA1238578A (fr) Forme pharmaceutique orale d'etoposide
KR20020048400A (ko) 레보시멘단의 약학적 액제
SA90100287B1 (ar) كبسولات صيدلية تحتوي على رانيتيدين
JP2001521495A (ja) 飲料用液体の単一製剤形のミネラルおよびビタミンの治療用組合わせ
US5002940A (en) Solid drug formulations and stable suspensions
US3966949A (en) Pharmaceutical compositions and preparing same
US4772589A (en) Etoposide solution in NMP
US20060040991A1 (en) Pharmaceutical presentation form for oral administration of a poorly soluble active compound, process for its preparation and kit
GB2331924A (en) Lipid compositions and their use
US4889862A (en) Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
EP0212853A2 (fr) Compositions parentérales à base de la phénytoine
WO2014149939A1 (fr) Solution thérapeutique liquide exempte de colorant
KR900000513B1 (ko) 에토포사이드 경구 투여용 조성물의 제조방법
US20050255161A1 (en) Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water

Legal Events

Date Code Title Description
MKEX Expiry